PHGE · BiomX Inc. · Exempt Offerings
$1.27
-0.58 (-31.35%)
At close · Sep 11
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's ability to continue as a going concern depends on its ability to obtain additional financing or to generate sufficient operating cash flows from its newly acquired subsidiaries, neither of which can be assured. These factors raise substantial doubt about the Company's ability to continue as a going concern. The condensed consolidated interim financial statements have been prepared on a going concern basis and do not include any adjustments that may result from the outcome of these uncertainties.”View the 10-Q filed Aug 19, 2026
Market Cap
$4.94M
Shares
2.67M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-01-20 | New | Pharmaceuticals | $3,300,000 | $3,300,000 | 06b |
| 2024-04-01 | New | Pharmaceuticals | $61,547,439 | $61,547,439 | 06b |
| 2023-03-03 | New | Pharmaceuticals | $7,484,390 | $1,461,324 | 06b |
| 2022-01-04 | New | Pharmaceuticals | $4,998,293 | $3,000,000 | 06b |
| 2021-10-25 | New | Pharmaceuticals | $3,000,000 | $3,000,000 | 06b |
Showing 1–5 of 5 filings